RhumbLine Advisers
MBIO icon

RhumbLine Advisers’s Mustang Bio MBIO Stock Holding History

RhumbLine Advisers’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$285 – 4341
2023
Q2 		$285 Buy
+1
New +$251 ﹤0.01% 4343
2022
Q2 		– Sell
-95
Closed -$72K – 3179
2022
Q1 		$72K Sell
95
-12
-11% -$9.86K ﹤0.01% 2943
2021
Q4 		$133K Buy
107
+5
+5% +$8.07K ﹤0.01% 2906
2021
Q3 		$205K Buy
102
+3
+3% +$6.44K ﹤0.01% 2909
2021
Q2 		$246K Buy
99
+53
+115% +$130K ﹤0.01% 2864
2021
Q1 		$115K Buy
46
+2
+5% +$5.95K ﹤0.01% 2920
2020
Q4 		$124K Buy
44
+9
+26% +$21.5K ﹤0.01% 2941
2020
Q3 		$83K Sell
35
-7
-17% -$17.3K ﹤0.01% 2901
2020
Q2 		$100K Buy
42
+3
+8% +$7.01K ﹤0.01% 2967
2020
Q1 		$79K Hold
39
– – ﹤0.01% 2816
2019
Q4 		$120K Buy
39
+1
+3% +$2.29K ﹤0.01% 2855
2019
Q3 		$93K Hold
38
– – ﹤0.01% 2896
2019
Q2 		$106K Buy
38
+12
+46% +$34.2K ﹤0.01% 2921
2019
Q1 		$66K Hold
26
– – ﹤0.01% 2902
2018
Q4 		$58K Buy
26
+8
+44% +$24.3K ﹤0.01% 2931
2018
Q3 		$79K Sell
18
-1
-5% -$5K ﹤0.01% 2887
2018
Q2 		$99K Buy
+19
New +$120K ﹤0.01% 2872

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers's MBIO Position: Q3 2023 in Review

RhumbLine Advisers sold out of Mustang Bio (MBIO) in Q3 2023, closing a stake of 1 share — an estimated $285 sold.

RhumbLine Advisers first reported a position in MBIO in Q2 2018 and held it in 17 quarters. The position peaked at $246K in Q2 2021. 26 funds tracked by Wall St. Rank hold MBIO as of Q3 2023.

  • RhumbLine Advisers reported no remaining Mustang Bio position as of Q3 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 1 Mustang Bio share in Q3 2023, an estimated $285.
  • RhumbLine Advisers first reported a position in Mustang Bio in Q2 2018 and held it in 17 quarters.
  • RhumbLine Advisers's Mustang Bio position peaked at $246K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2023.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.